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http://dx.doi.org/10.1016/j.asjsur.20Summary Background: Laparoscopic cholecystectomy uses smaller incision and trocars that
lessen the contamination and exposure of wound, resulting in less infection. However, the
antibiotic prophylaxis is still widely practiced, like in our institute, a continuation of the era
of open surgery. Recent studies reveal no advantage of routine use of antibiotic, and there
is growing consensus against it. Besides cost, antibiotic increases emergence of multidrug
resistance. Because of the controversies, we conducted this clinical trial.
Methods: This randomized clinical trial, conducted from October 1, 2009 to September 31,
2010 at Patan Hospital, included 154 patients in prophylactic antibiotic group (GrAP) with ce-
fazolin 1 g IV as per existing practice and 156 in no antibiotic group (GrAPn). Symptomatic lapa-
roscopic cholecystectomy patients of American Society of Anesthesiologist (ASA) 1 and 2
(without diabetes) were included. Patients with complicated gall stones (cholangitis, choledo-
cholithiasis, and pancreatitis) and who required conversion were excluded. Wound was
observed during follow-up within 1 week. Data on patient characteristics, use of antibiotic,
bile spillage, and postoperative wound infection were entered in predesigned proforma. Micro-
soft Excel was used to analyze the data.
Results: In total, 310 patients were eligible for analysis, 154 in GrAP and 156 in GrAPn. Both
groups were comparable in patient demographic and clinical characteristics such as average
age (40.3 vs. 41.6 years) and sex (female 77.6% vs. 78.6%). Overall wound infection occurred
in 4.8% (15/310). There was no significant difference in wound infections among the two groups
(p Z 0.442): GrAP 3.9% and GrAPn 5.8%. There was no mortality in this series.t of Surgery, Patan Hospital, Patan Academy of Health Science (PAHS), Lalitpur, GPO Box 252,
il.com, jayshah@pahs.edu.np (J.N. Shah).
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Antibiotic in laparoscopic cholecystectomy 137Conclusion: Routine preoperative antibiotic prophylaxis is not necessary in low-risk symptom-
atic gallstone patients undergoing laparoscopic cholecystectomy.
Copyright ª 2012, Asian Surgical Association. Published by Elsevier Taiwan LLC.
All rights reserved.Table 1 Findings in laparoscopic cholecystectomy
patients (n Z 310), GrAP and GrAPn.
Laparoscopic
cholecystectomy
patients
GrAP n% GrAPn n%
Number of patients 154 156
Age (y) 40.3 (13e76) 41.6 (10e76)
Female 121 78.6 121 77.6
Male 33 21.4 35 22.4
Bile spillage 52 33.8 46 29.5
Acute biliary attacka 11b 7.1 20b 12.8
SSI (stitch abscess,
erythema, discharge)
6 3.9 9 5.8
GrAP Z antibiotic prophylaxis group; GrAPn Z no antibiotic
prophylaxis group; SSI Z surgical site infection.
a Without leucocytosis, fever, or findings of suppurative
cholecystitis, empyema, or gangrenous gallbladder during
surgery.
b Two out of 11 and four out of 20 also had bile leak.1. Introduction
Laparoscopic cholecystectomy (LC) has now come of age as
a safe surgery for symptomatic cholelithiasis. Regarding the
use of antibiotic prophylaxis (AP) in LC, despite the contro-
versies, there is a growing consensus in support of not using
AP in uncomplicated cases.1e5 However, clinicians do not
give up the traditional practice easily despite the fact that
recent meta-analysis and reviews support this view.
Preoperative single-dose cefazolin as an AP has been
recommended (by the Centers for Disease Control and
PreventiondCDC) and widely used in clean-contaminated
surgery such as cholecystectomy and biliary surgery to
reduce surgical site infection (SSI).6,7
The benefit of LC as a minimally invasive surgery has
been recognized for its faster recovery, but the use of AP
has remained similar to that of the era of open cholecys-
tectomy. This needs re-evaluation because the role of AP to
prevent SSIs is controversial in LC due to low risk of SSI. In
LC, the incision is smaller and manipulation is done through
trocars that lessen the contamination and exposure of
wound, unlike in open surgery.8e16
Unnecessary use of antibiotic adds to the cost and
increases emergence of multidrug resistance. Because of
the controversies on routine use of AP in LC, we conducted
this prospective trial on the necessity of our existing
practice of using single-dose cefazolin as AP in LC.
2. Patients and methods
This randomized clinical trialwas carried out fromOctober 1,
2009 to September 31, 2010 at Patan Hospital, a university
teaching hospital with optimum operating, anesthetic, and
recovery facilities, with the aim of including 150 patients in
each group. Patients were randomized into two groups by
lottery. Odd-numbered (1 and subsequent 3, 5,.) patients
received antibiotic prophylaxis (GrAP), whereas even
numbered (2 and subsequent 4, 6, .) did not receive anti-
biotic prophylaxis (GrAPn). Operation-room nurses adminis-
tered antibiotics to the odd-numbered patients.
Symptomatic patients scheduled for LC of ASA 1 and 2
(without diabetes) who consented for the study were
included. Patients with complicated gall stones (chol-
angitis, choledocholithiasis, and pancreatitis) and those
who required conversion to open cholecystectomy were
excluded. Acute cholecystitis with high leukocyte count
(>11,000) and fever (>100F) prior to surgery were not
included in the study. Patients who were found to have
suppurative cholecystitis, empyema, or gangrenous gall-
bladder during surgery were also excluded. However,
patients with acute biliary attack of right upper quadrant
pain admitted through emergency department were
included. The study was approved from the hospitalauthority. All LCs were performed under general anesthesia
with endotracheal intubation. Patients were monitored
postoperatively as per our existing practice.
For postoperative analgesia, morphine 4e6 mg (0.1 mg/
kg) and Phenergan 25 mg were administered intramuscularly
every 4 hour as required, together with oral paracetamol
500 mg and ibuprofen 400 mg. Oral feeding was started after
4 hours of surgery. Drip was stopped 6 hours after surgery,
with cannula being locked in situ. Patients were discharged
on 1st postoperative day (if vitals were stable with no
features of peritonitis and if patients could tolerate oral
feeding). They were advised to follow up in surgical referral
clinic within a week. Status of wound (normal, inflamed, or
pus) was recorded and managed accordingly with cipro-
floxacin 500 mg twice daily for inflammation, plus gaping/
dressing of wound in case of pus.
Patient demographics and clinical characteristics,
including gall bladder perforation and bile/stones spillage
during surgery, were recorded in a predesigned proforma.
Microsoft Excel and SPSS were used to analyze the data.
3. Results
During the study period, a total of 328 LC patients were
enrolled out of which 18 were excluded because of
incomplete data. Among the remaining 310 patients eligible
for analysis, 154 were in GrAP and 156 in GrAPn. Both
groups were comparable in patient demographic and clin-
ical characteristics (Table 1).
Inadvertently, perforation and spillage of bile occurred
in 96 cases of which 25 also had spillage of stones. Spilled
Table 2 Wound infection among two groups of LC patients
with and without prophylactic antibiotic had no significant
difference (chi-square test, p > 0.05 or p Z 0.442).
LC patients Wound
infection n%
No wound
infection n%
GrAP, n Z 154 6a 3.9 149 96.1
GrAPn, n Z 156 9a 5.8 147 94.2
Total, n Z 310 15 4.8 295 95.2
GrAP Z antibiotic prophylaxis group; GrAPn Z no antibiotic
prophylaxis group; LC Z laparoscopic cholecystectomy.
a None of these patients were from the subgroup of acute
cases.
138 J.N. Shah et al.stones were picked up and irrigation with normal saline was
performed until the aspirate was clear.
The overall SSI occurred in 4.8% (15/310) of patients. Six
SSI out of 154 (3.9%) occurred in GrAP and nine out of 156
(5.8%) in GrAPn. This slightly higher incidence of SSI in
GrAPn was not significant (chi-square test, p > 0.05 or
p Z 0.442; Table 2). There was no bile duct injury or
mortality in this series. Average hospital stay after surgery
was 1.27 (range 1e3) days in GrAP and 1.32 (range 1e3)
days in GrAPn.4. Discussion
Protocol to AP at our institutions has continued ever since
the era prior to the introduction of minimal invasive LC two
decades ago. Like many other institutions in and out of the
country, all cholecystectomy patients at our hospital
routinely receive AP (cefazolin 1 g IV) prior to surgery. In
the present study, the overall SSI was 4.8%. The SSI was
3.9% in GrAP and 5.8% in GrAPn. The slightly higher occur-
rence of wound infection in GrAPn was statistically not
significant (chi-square test, p > 0.05 or p Z 0.442). Our
findings are comparable with reported studies.1e3,5,8,9
Iatrogenic gallbladder perforation in LC occurs in 2e25%
of cases.2,4,17e19 In the present study, we had higher inci-
dence of bile leakage spillage (30.9%, 96/310). Possible
cause could be involvement of acute cases (10%) and
different levels of operating surgeons, from lecturer to
professors. Findings of this study does not support the
general perception that bile leak increases the SSI. Out of
45 bile spillage in GrAPn (156 LC), there were only five SSIs
out of the nine that had spill during surgery. Similarly in
GrAP (154 LC), there were 50 bile spills, but none of the six
SSIs had any history of bile spill. Other studies have re-
ported similar findings.8,17,20
We did not include body mass index (BMI) as a possible
variable to influence wound infection in open surgery,
because BMI is not considered a risk factor in minimal
invasive LC with small incision. In case of LC, studies have
not found differences in operative time, length of stay, or
complications between normal-weight and overweight or
obese patients.21e23 Moreover, BMI of patients we see in our
local society seldom exceeds 30.
Our institutional policy is to perform surgery during index
admission for acute cases if they can be scheduled within 1
week of attack. In this study, we included patients who wereadmitted from emergency department with acute biliary
pain (without the features of “acute infection” such as high
leucocyte count and fever, and findings of empyema,
gangrenous or suppurative cholecystitis-thickened and
edematous “hot” looking gallbladder during surgery).
Subgroup analysis revealed that 11 acute cases (two also
had bile spill during surgery) in GrAP and 20 (with four bile
spill) in GrAPn who had LC during the admission did not
develop SSIs. Study with larger sample size may be required
to generalize our findings that patients with acute attack
(but without features of suppurative cholecystitis,
empyema, and gangrenous gallbladder) do not benefit from
routine AP to prevent SSIs.
There was no difference in average hospital stay after
surgery, with 1.27 (range 1e3) days in GrAP and 1.32 (range
1e3) days in GrAPn. Our practice is to discharge patients on
the 1st postoperative day following LC unless their condition
is complicated (example: unstable vitals or peritonitis due
to bile leak) or they are not willing to go home (due to
transportation problem when living far from the hospital).
In this study, we had no bile leak or duct injury. Our
hospital policy is to admit patients for elective surgery 1
day (unit-1) and 2 days (unit-2, because hospital is closed
on the day prior to surgery) earlier for checkup. Also,
because of transportation problem we cater service to
patients from all over the country and even from within the
town, if required. This is the reason why some of our
patients who could be discharged medically stayed 1e2
days more after surgery.
This study has some limitations. We did not include
patients with “acute cholecystitis” who had high leukocyte
count, fever on admission, or findings of suppurative
cholecystitis, empyema, or gangrenous gallbladder during
surgery. Thus, our findings cannot be generalized to all
patients who undergo surgery for acute cholecystitis
because they are already on antibiotic when admitted from
emergency department. This will require separate study
with different sorts of protocols. At our institute, we
perform “emergency” cholecystectomy for patients
admitted within a week of attack, on any of the four
scheduled operation days. Otherwise, they are advised for
surgery after 6 weeks or more. We consider “emergency
surgery” out of normal operating schedule when there is
a complication such as peritonitis due to gangrenous or
gallbladder perforation.
Risk of SSI in LC is low and does not seem to be reduced
by the routine use of AP in uncomplicated cases, as we
found in this study. Based on recent published evidences
and after the completion of our own study, we have now
adopted the policy of not administering routine AP in
uncomplicated cases of LC. Most of the published data come
from developed countries that may have different patient
and social structures. We hope that being conducted in
a local scenario this study will help other institutions in
Nepal as well as in other developing countries with similar
socioeconomic condition to benefit from its findings.5. Conclusions
Already low risk of wound infection following LC was not
significantly reduced further with the routine use of
Antibiotic in laparoscopic cholecystectomy 139preoperative AP in uncomplicated patients with symptom-
atic cholelithiasis.
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